SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending after reporting record fourth-quarter results and fiscal 2027 guidance that exceeded analyst expectations, driven by a surge in backlog orders. While the company faces pressure from ongoing profit-taking and volatility, sentiment remains highly bullish due to strong fundamentals in the power infrastructure and data center sectors.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and imminent Phase 2 NSCLC trial data following the company's recent healthcare conference presentations. Investors are expressing confidence in the company's commercial growth, clinical pipeline, and management's stated progress toward profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as traders speculate on potential acquisition interest from a mid-to-large cap biopharma, though market participants remain divided on the validity of these reports. Long-term investors are focused on the commercial growth of Briumvi and upcoming data catalysts, suggesting the stock remains a strong prospect even without an immediate buyout.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon stock faces continued downward pressure as the community discusses concerns over heavy capital expenditure for AI infrastructure and potential data losses at Middle Eastern facilities, while traders debate the impact of broader market headwinds like rising yields and Fed rate expectations.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is trending following reports that the company received conditional grid capacity classifications from ERCOT for a significant portion of its pipeline, fueling optimism about its transition into an AI power infrastructure provider. While the news sparked momentum, sentiment remains divided as traders debate the scale of the approval versus market expectations and monitor broader macro-economic factors surrounding data center investments.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is receiving significant attention following the completion of its acquisition of LivePerson, which traders are debating as either a strategic move to boost enterprise scale and profitability or a risky gamble due to integration concerns and share dilution. While some investors view the current price weakness as a buying opportunity given the potential for a short squeeze and long-term growth, others remain skeptical, citing persistent downward price action, management criticism, and concerns over the company's path to profitability.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as investors weigh mixed signals regarding its turnaround efforts, with some focusing on reports of rising afternoon traffic and a potential stake sale in its Japan business, while others express skepticism over valuation and the competitive landscape.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel shares are trending following a report that SK Hynix is in exploratory talks to potentially manufacture memory chips at Intel's Ohio facility. While the community is debating the significance of the potential partnership, many are viewing the news with caution as both companies have indicated that no final agreement has been reached.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending as investors react to strong financial performance, including a milestone quarterly profit, and positive analyst sentiment regarding its AI-driven expansion and growth potential. While some traders express frustration with the stock's historical price volatility and lingering macro concerns, others maintain a bullish long-term outlook centered on its successful scaling in Latin America and future entry into the U.S. market.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense selling pressure as traders debate its status as a defensive blue chip in a challenging consumer environment, with many pointing to the stock hitting new 52-week lows. While some investors view the current valuation as a generational buying opportunity due to the company's real estate holdings and dividend, others remain bearish, citing concerns over restaurant traffic, pricing power, and broader economic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After Golden Cross, Biomea Fusion, Inc. (BMEA)'s Technical Outlook is Bright

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Are Medical Stocks Lagging  Brookdale Senior Living (BKD) This Year?

Here is how Brookdale Senior Living (BKD) and Biomea Fusion, Inc. (BMEA) have performed compared to their sector so far this year.

Biomea Fusion Stock Surges on Phase II Diabetes Trial Enrollment Completion

Shares of Biomea Fusion are trading sharply higher on Monday following an operational milestone for its lead metabolic drug program.read more...

Biomea Fusion Status Update: Experts Discuss Icovamenib's Promise Ahead of ADA 2026

Rodman & Renshaw Director of Research Michael King hosted an endocrinology-focused discussion with Dr. Alexander Abitbol, an endocrinologist and assistant medical director at LMC Healthcare, ahead of the American Diabetes Association (ADA) meeting in New Orleans. The conversation centered on tre...

Biomea Fusion (NASDAQ:BMEA) Coverage Initiated by Analysts at Citizens Jmp

Citizens Jmp began coverage on shares of Biomea Fusion in a research note on Tuesday. They issued a 'market outperform' rating and a $9.00 target price on the stock...

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of "Moderate Buy" from Analysts

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings...

Biomea Fusion Shares Early Type 1 Diabetes Data as COVALENT-112 Shows C-Peptide Gains with Icovamenib

Biomea Fusion (NASDAQ:BMEA) executives highlighted early, exploratory clinical data for icovamenib in type 1 diabetes, presenting top-line results from the company's COVALENT-112 proof-of-concept...

Biomea Fusion (NASDAQ:BMEA) Given Buy Rating at D. Boral Capital

D. Boral Capital reissued a "buy" rating and issued a $12.00 price objective on shares of Biomea Fusion in a research report on Tuesday...

Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Monday

Biomea Fusion (NASDAQ:BMEA) will be releasing its Q1 2026 earnings before the market opens on Monday, May 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-4-biomea-fusion-inc-stock...

Biomea Fusion (NASDAQ:BMEA) Receives Buy Rating from D. Boral Capital

D. Boral Capital restated a "buy" rating and issued a $12.00 price objective on shares of Biomea Fusion in a research note on Wednesday...

This account has been verified as an official BMEA representative.

Verified Account

Biomea Fusion IR

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in San Carlos, CA.

Biomea Fusion Inc

Biomea Fusion Slides After-Hours Following Stock-And-Warrant Offering; Retail Traders See Rebound Ahead

Equity

Bullish Sentiment

Hike and the market rallies

Hike and the market falls

No change and the market rallies

No change and the market falls

The Federal Reserve's rate decision lands today at 2:00 PM ET. What do you think the Fed decides today, and how does the market react afterward? Vote and explain your reasoning in the comments.

What do you think the Fed decides today, and how does the market react? 
 
Drop a comment with the percentage move you expect.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.23	--	--	N/A
Q2 '26	-$0.22	-$0.12	46.30%	BEAT
Q1 '26	-$0.23	-$0.17	26.50%	BEAT
Q4 '25	-$0.23	$0.40	273.77%	BEAT
Q3 '25	-$0.26	-$0.27	-5.37%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

BMEA Earnings

Upcoming Earnings: Q3 '26

Historical Earnings